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Abstract
Background: p38 MAPK activity plays an important role in several steps of the osteoblast lineage progression through
activation of osteoblast-specific transcription factors and it is also essential for the acquisition of the osteoblast phenotype
in early development. Although reports indicate p38 signalling plays a role in early skeletal development, its specific
contributions to adult bone remodelling are still to be clarified.
Methodology/Principal Findings: We evaluated osteoblast-specific deletion of p38a to determine its significance in early
skeletogenesis, as well as for bone homeostasis in adult skeleton. Early p38a deletion resulted in defective
intramembranous and endochondral ossification in both calvaria and long bones. Mutant mice showed reduction of
trabecular bone volume in distal femurs, associated with low trabecular thickness. In addition, knockout mice also displayed
decreased femoral cortical bone volume and thickness. Deletion of p38a did not affect osteoclast function. Yet it impaired
osteoblastogenesis and osteoblast maturation and activity through decreased expression of osteoblast-specific
transcription factors and their targets. Furthermore, the inducible Cre system allowed us to control the onset of p38a
disruption after birth by removal of doxycycline. Deletion of p38a at three or eight weeks postnatally led to significantly
lower trabecular and cortical bone volume after 6 or 12 months.
Conclusions: Our data demonstrates that, in addition to early skeletogenesis, p38a is essential for osteoblasts to maintain
their function in mineralized adult bone, as bone anabolism should be sustained throughout life. Moreover, our data also
emphasizes that clinical development of p38 inhibitors should take into account their potential bone effects.
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Introduction
During development, ossification depends on the activity of
osteoblasts that are derived from mesenchymal stem cells.
Throughout this process of osteoblastic differentiation, osteochon-
droprogenitors proliferate and go through a series of steps before
becoming mature osteoblasts [1,2,3]. Furthermore, osteocytes are
derived from terminally differentiated osteoblasts that remain
embedded in the bone-mineralized matrix. Later on in adulthood,
bone formation and remodeling remain very dynamic processes
that rely on a tight balance between osteoclast resorption and new
bone formation by osteoblasts. Any disparity between these two
activities causes pathological states such as osteoporosis [4].
Many extracellular stimuli, such as mechanical stress, inflam-
matory cytokines and growth factors, have been described as
regulators of osteoblast differentiation through p38 MAPK
signalling [5]. In mammalian cells, four isoforms of p38
Mitogen-Activated Protein Kinases (MAPKs) have been described:
p38a (MAPK14), b (MAPK11), c (MAPK12) and d (MAPK13)
[6]. Some differences in activation have been shown between
distinct isoforms, with p38a MAPK being one of the most
abundant isoform in osteoblasts and bone [7]. p38 MAPKs are
activated by MKK3 and MKK6, which are also downstream of
several MAPKKKs, including TAK1, ASK1 and MLKs [6].
p38 MAPK activity, known to play an important role in several
steps of the osteoblast lineage progression, is necessary but not
sufficient for BMP-induced acquisition of the osteoblast phenotype
[8,9,10]. Evaluation of these effects is often based on the
commonly used inhibitor, SB203580, which only inhibits p38a
and p38b isoforms. Biochemical analysis has identified key
osteogenic genes whose expression and/or function are regulated
by p38. Evidence shows that p38 activity is required for BMP-
induced Osx expression in calvaria, as well as bone-marrow-
derived mesenchymal stem cells [11,12,13]. Moreover, several
reports indicate that p38 phosphorylates critical transcription
factors involved in osteoblastogenesis such as DLX5, RUNX2 and
OSX [7,13,14,15,16]. Phosphorylation by p38 regulates their
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transcriptional activity by promoting association with transcrip-
tional coactivators and chromatin remodeling complexes
[7,13,14,17].
p38 signalling in early bone development has also been studied
in mouse models. Analyses of mice lacking TAK1, MKK3 or
MKK6 display profound defects in bone formation and develop-
ment. However, these defects differ depending on anatomical
location. For instance, only MKK6 contributes to calvarial
mineralization [5,7]. The study of developing long bones of mice
with specific deletion of p38a in osteoblasts showed a progressive
decrease in bone mineral density in cortical and trabecular bone
[18]. Although existing reports indicate the role of p38 signalling
in early bone formation and skeletogenesis, its specific contribu-
tions to adult bone remodelling are still to be clarified. In earlier
models p38 signalling was impaired in osteochondroprogenitors or
osteoblasts during early bone formation both in utero and
perinatally [7,18]. Furthermore, it has been hypothesized that,
whereas p38a is required for early osteoblast differentiation, p38b
is the main isoform involved in late maturation and postnatal
function [7].
Here, we evaluated osteoblast-specific deletion of p38a to
determine whether it is necessary in early skeletogenesis as well as
for bone homeostasis in adult bones. Early p38a deletion results in
defective intramembranous and endochondral ossification through
decreased expression and function of osteoblast-specific transcrip-
tion factors and their targets. More importantly, deletion of p38a
at three or eight weeks postnatally leads to significantly lower
trabecular bone volume at 30 weeks and lower cortical volume
and thickness at 60 weeks. These results demonstrate that p38a
plays an essential role in the maintenance of osteoblast function
during bone remodeling and that clinical development of p38
inhibitors should take into account their potential effect on bone.
Results
Osteochondroprogenitor-specific deletion of p38a in
mice
To determine the function of p38a MAPK, we generated mice
whose p38a was selectively disrupted in osteochondroprecursors
under the control of a tetracycline-responsive promoter (Osx1-
GFP::Cre) [19]. Osx1-GFP::Cre:p38aflox/flox mice, grown in the
absence of doxycycline treatment (hereafter referred to as p38a
knockout mice, KO), were born with the expected Mendelian
frequency. Their viability was indistinguishable from those of
control mice (p38aflox/flox; FF).
Efficiency of Cre activity, assessed by PCR analysis of calvarial
DNA, stood at 50% to 80% (Fig. 1A). Osx1::Cre-mediated floxed
recombination occurred exclusively in tissues that contain
osteoblasts, whereas other tissues of mesenchymal origin retained
intact floxed alleles (data not shown). In line with results from a
previous report, body weight in male Osx1GFP::Cre mice was
lower than in control littermates [20]. However, body weight of
knockout mice was significantly lower than that of either control
(FF) or Osx1-GFP::Cre mice (Figure S1). We further analyzed
p38a expression in calvaria and tibia, as well as osteoblasts isolated
from knockout mice and control littermates. In bone tissues and
cultured osteoblasts we obtained a 60% reduction in p38a mRNA
expression with no significant changes in the expression levels of
the other p38 MAPK isoforms (Fig. 1B–C). Reduction in the p38a
mRNA levels also resulted in decreased p38a protein expression in
the calvaria of p38a-deficient mice (Fig. 1D). Interestingly, when
phosphorylated levels of p38 isoforms or CREB (a target of p38
MAPK signalling) were analyzed, they had been reduced by about
the same extent as p38a protein levels (Fig. 1D). These data
suggest that the p38a isoform contributes to the total p38 MAPK
signalling in mature osteoblasts.
Figure 1. p38a specific-deletion in osteoblast progenitors. (A) PCR of calvarial bones of control (FF) and knockout (KO) mice using specific
primers against Mapk14 (p38a) demonstrate gene deletion in KO mice after Cre-mediated recombination. (B) qRT-PCR of mRNA from calvaria or tibia
displays p38a (MAPK14) reduced expression in knockout versus control littermates (n = 7 for KO and 13 for FF). (C) Expression of p38 isoforms in
primary osteoblasts (p38a/MAPK14; p38b/MAPK11; p38c/MAPK12; p38d/MAPK13) (n = 6 independent animals). (D) Calvarial protein levels of p38,
phospho-p38, Creb, and phospho-Creb show impaired MAPK signalling in knockout animals (n = 3 independent animals) (*p,0.05; **p,0.01; ***p,
0.001).
doi:10.1371/journal.pone.0102032.g001
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Cranio-facial and skeletal alterations in p38a knockout
mice
Skeletal preparations of newborn knockout mice showed
hypoplastic cranio-facial bones compared to littermate controls
In particular, impaired mineralization of frontal and parietal bones
and delayed posterior fontanel ossification (Fig. 2A). Later, X-ray
images further confirmed a hypomineralization of the calvaria and
abnormal development of the maxilla and mandible in 8 week-old
mice (Fig. 2B). Skeletal preparations showed no other obvious
changes in the overall skeletal structure, although a small but
significant decrease in the length of long bones was observed in
knockout mice (femur length of knockout mice was 92% that of
control mice). Both male and female knockout mice similarly
displayed these cranio-facial phenotypes (data not shown).
Histological evaluation of calvaria from p38a knockout and
control mice at 12 weeks of age showed a substantially lower
thickness in knockout than in control mice (Fig. 3A). Similarly,
staining of proximal tibiae and distal femurs showed thinner
cortical bone and a significantly smaller trabecular area in tissues
from knockout than in tissues from control or Osx1-GFP::Cre
mice (Fig. 3B&C). These data indicate that deletion of p38a in
osteochondroprogenitors leads to a strong decrease in bone mass
of both intramembranous and endochondral origins. They also
corroborate previous reports showing that the bone phenotype in
young Osx1-GFP::Cre mice was overcome by 12 weeks of age,
with no differences observed between Osx1-GFP::Cre and control
mice [20,21]. There was no change in the number of osteocytes
per area but, since the cortical area in p38a-deficient tibiae was
lower, the total number of osteocytes was also lower in cortical
samples from knockout mice (Fig. 3C).
For more accurate measurements of bone structure, trabecular
and cortical bone architecture were assessed by micro-computed
tomography (mCT) in male mice. Collectively, the mCT quanti-
tative results confirmed histological images. p38a-deficient adult
mice at 12 weeks of age showed less trabecular bone volume in
distal femurs associated with low trabecular thickness (17% less)
and a significantly lower trabecular number (Fig. 4A). In addition,
knockout mice also displayed decreased femoral cortical bone
volume and thickness (30% and 19% reduction, respectively)
(Fig. 4B).
Disruption of p38a impairs osteoblast differentiation and
function
In order to discern if p38a affects osteoblastogenesis, we
conducted colony-forming assays from bone marrow cultures.
Undifferentiated mesenchymal cells from long bones did not show
differences in fibroblastic colony forming units. After culturing
them for 18 days in osteoblast differentiation medium, cell cultures
were stained for alkaline phosphatase activity, showing a
significant decrease (24% reduction) in KO alkaline phospha-
tase-positive colonies when compared to FF cultures (Fig. 5A). To
further characterize the osteoblastic role of p38a, RNA was
isolated from both the calvaria and bone marrow-flushed tibia of
mice at 12 weeks of age. Expression of osteoblast genes from p38a-
deficient mice and littermate controls was measured by qPCR
(Fig. 5B,C). Expression of the early osteoblast differentiation
marker Col1a1 was decreased in calvaria and tibia (reaching a
significantly lower value only in tibiae). In addition, expression of
the late osteoblast differentiation markers bone sialoprotein (Ibsp),
fibromodulin (Fmod) and osteoglycin (Ogn) [3,22] fell to a greater extent,
as did the known osteocyte markers Dkk1, Fgf23 and sclerostin (Sost)
[23] (Fig. 5B,C). These results indicate that progression of
osteoblast differentiation in vivo is defective in knockout mice,
beginning at an early stage and more dramatic at later stages.
To grasp the mechanisms for such transcriptional effects on
osteogenic markers, expression of osteoblast-specific transcription
factors was also analyzed at 12 weeks of age. Expression levels of
Dlx3, Dlx5 or Runx2 were, at most, only slightly lower in tibiae and
calvarial tissues of knockout mice and Msx2 was only significantly
lower in calvarial samples. However, Id1 or Osx, which are
induced later in development [13,24,25], showed significantly
lower expression in both calvaria and tibiae of knockout mice
(60% less than in control mice). Reduction in the Osx mRNA levels
also resulted in lower OSX protein levels in the calvaria of p38a-
deficient mice, whereas there was no change in RUNX2 protein
levels (Fig. 5D).
p38a-deficient mice did not show significant changes in the
serum alkaline phosphatase levels, a known marker of bone
formation [26]. Similarly, calcium and phosphate levels in serum
and urine remained unchanged between knockout and control
littermates (Figure S2). Rankl and Opg mRNA expression was
analyzed in tibiae from mice at 12 weeks of age to determine
whether increased osteoclastogenesis could also explain the lower
bone mass of knockout mice. Both Rankl and Opg expression were
lower in knockout mice. However, the relative Rankl/Opg ratio,
which determines osteoclast activation [27], was not significantly
altered (Fig. 6A,B).Similarly, expression of the osteoclast marker
Trap (tartrate-resistant acid phosphatase) was not modified
(Fig. 6A). To further explore changes in bone resorption, we
measured cross-linked N-terminal telopeptides of type I collagen
(NTX) levels in serum of fed and fasted mice [28]. NTX levels
were slightly lower in serum of p38a-deficient mice, although they
did not reach significant variation (p = 0.061) (Fig. 6C). Moreover,
specific staining for TRAP activity in tibiae preparations did not
show gross differences in the number of positive cells or in the ratio
between osteoclast surface and trabecular bone surface (Fig. 6D).
These results indicated that p38a inactivation in osteoblasts did
not increase osteoclast function, and that the reduced bone mass in
these mice was not due to increased bone resorption.
Figure 2. p38a deletion is associated with bone developmental
defects. (A) Alcian blue/alizarin red staining of P7 mice pups. Alcian
blue and alizarin red stain cartilage and calcified structures respectively
(FB: frontal bone; PB: parietal bone; PF: posterior fontanel) (B)
Radiographic lateral projections of 8-week old mice show maxilla and
mandible hypoplasia (# marks maxilla and * marks mandible).
doi:10.1371/journal.pone.0102032.g002
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To further explore the cell mechanism involved in the bone
phenotype of p38a-deficient mice, we isolated and analyzed
primary osteoblasts in vitro from knockout and control littermates.
In isolated calvaria, as well as freshly isolated osteoblasts from
knockout mice, expression of the EGFP-Cre transgene was evident
in almost all osteoblasts (Fig. 7A). Once the osteoblasts were
cultured in vitro, EGFP-Cre expression declined over time.
Osteoblasts from knockout or control mice showed no significant
differences in their proliferation rate under media with or without
fetal bovine serum as mitogenic stimulus (Fig. 7B). Osteoblasts
from knockout and littermate controls were also cultured to
confluence in osteogenic media for 10 days and their RNA was
extracted and analyzed. As previously found for calvaria and tibia
samples, Runx2 expression was unaltered and Col1a1 expression
was slightly lower without reaching significance, whereas the
markers of late differentiation osteocalcin (Bglap) and Osx showed
significantly lower values than osteoblast cultures from control
animals (Fig. 7C). Taken together, these results indicate that p38a-
deficient osteoblasts have a cell-autonomous defect in differenti-
ation potential and further osteogenic function.
Skeletal alterations after deletion of p38a in adult mice
To evaluate the role of p38a in fully formed bones, doxycycline
was delivered in drinking water to pregnant mothers and to
newborn mice until 3 or 8 weeks of age. Doxycycline represses the
Osx1-GFP::Cre promoter and recombination at the p38a locus
(exons 2–3) is prevented until doxycycline is removed from
drinking water [19]. Mice that received doxycycline until 3 weeks
after birth were killed at 30 or 60 weeks of age and those that
received doxycycline until 8 weeks of age were killed at 60 weeks
(Fig. 8A). qRT-PCR analysis showed that p38a expression was
reduced (60% compared to control) in bones of mice at 30 or 60
weeks of age (Fig. 8D). mCT analysis was performed on distal
femurs of these mice. Whereas we found no major changes in
cortical parameters with age in control animals, there was an age-
dependent 42% decrease in trabecular bone volume accompanied
by a decrease in trabecular number in control animals by 31%
(Fig. 8B,C and Figure S3). These results fully corroborate previous
data on C57BL/6 mice [29]. Cortical analysis at the femoral mid-
shaft showed that deletion of p38a three weeks postnatally results
in minor differences in cortical bone parameters after 30 weeks.
However, 60 weeks after p38a deletion bone volume was lower
(16% reduction) due to a significant decrease in cortical thickness
(Fig. 8C and Figure S3). Similarly, deletion at 8 weeks after birth
and analysis at 60 weeks showed lower bone volume (9% less in
KO animals) and a reduction in cortical thickness (12% thinner).
These results suggest that postnatal deletion of p38a results in
cumulative effects over time on cortical bone turnover.
In contrast to the late effects (60 weeks) of p38a deletion on
femoral cortical thickness, the effects in trabecular bone were more
clearly seen at early ages. Deletion of p38a three weeks postnatally
led, after 30 weeks, to reduced bone volume and trabecular
number (20% and 16% reduction, respectively) but no changes in
trabecular thickness (Fig. 8B). However, after 60 weeks there were
Figure 3. Histological analysis of bones from control and p38a knockout mice. (A) Representative images of calvarial sections stained with
H&E. Right panel shows quantification of calvarial thickness (n = 5 independent animals). (B) Representative images of long bone sections stained
with H&E. Quantification of trabecular area and trabecular number from tibiae sections are shown in the right panel (n = 3 (KO) and 4 (FF)
independent animals). (C) Thickness and osteocyte count from cortical areas of long bone stained with toluidine blue (n = 3–6) (*p,0.05; **p,0.01;
***p,0.001).
doi:10.1371/journal.pone.0102032.g003
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no significant changes in the trabecular bone parameters in
animals with p38a deletion at either 3 or 8 weeks (Fig. 8B and
Figure S3). These data suggest that the effects of age-dependent
reduction on trabecular bone could make it difficult to detect
differences between groups [30]. Alternatively, progressive age-
dependent reduction in trabecular number could dampen the
p38a deletion effects in order to maintain some biomechanical
competence. Moreover, our data reinforce the idea that bone
remodelling has different patterns on cortical and trabecular
surfaces [29,31,32]. We also analyzed the expression of osteoblast
markers in animals at 30 weeks of age and treated them with
doxycyline until 3 weeks of age. qRT-PCR data showed invariant
levels of Runx2 mRNA but a significant decrease in the late
osteogenic markers Ibsp, Osteocalcin and Osx (Fig. 8D)
Discussion
Recent studies have documented the importance of p38
signalling in skeletal development in vivo. Mice in which TAK1,
MKK3 or MKK6 were deleted in osteochondroprogenitors from
early development had low bone mass phenotype due to impaired
osteoblast differentiation [7]. Similarly, when p38a deletion in
osteoblasts occurred during late embryogenesis, mice developed a
progressive decrease in bone mineral density (BMD) [18]. These
effects also appeared with a different temporal pattern. For
instance, inactivation of p38 signalling in osteochondroprogenitors
(Osx1-GFP::Cre) (deletion around E14–15 [19]) resulted in
skeletal defects in newborn mice, whereas inactivation in late
embryogenesis (E-16.5–18.5) in Ocn-Cre showed no significant
alterations before five weeks of age [7,18,33].
Our results confirm that p38a is critical for early bone
formation and development; they also demonstrate this require-
ment for bone homeostasis in adulthood. We took advantage of an
inducible Cre system that controls the onset of p38a disruption
after birth by removing doxycycline from drinking water [19]. We
performed the deletion of p38a at 3 weeks of age, when the bone
architecture is already established, and BMD and cortical
thickness is about 60–70% of that of adult mice, or at 8 weeks
of age, when mineralization in cortical and trabecular bone has
already reached peak values [29,31,34,35]. Significant trabecular
bone loss was detected at 30 weeks of age. However, at 60 weeks of
age cortical bone volume and thickness were lower while
differences from control mice in trabecular bone volume and
number no longer persisted in p38a knockout animals. In
confirmation of our results, most previous studies in aged mice
in B6 background established that trabecular bone loss was mostly
dependent on complete elimination of individual trabeculae,
whereas trabecular thickness was not affected and sometimes even
increased [29,36,37]. This effect mirrors morphological traits of
osteoporosis in humans [38,39]. In our model, p38a had a
significant effect on bone remodelling after 30 weeks of age. One
can speculate that, later on, these effects could be tempered by the
age-dependent reduction in trabecular bone, to maintain some of
the latter’s biomechanical competence in face of decreasing
Figure 4. mCT evidences osteopenic bones in p38a deficient bones of 12-week-old mice. (A) The distal epiphysis of femurs from control
and knockout littermates were analysed by mCT. Trabecular bone volume (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th) and
trabecular separation (Tb.Sp.) were determined (n = 8 (KO) and 12(FF)). (B) Femur cortical bone analysis of 12-week-old male mice revealed that
knockout mice had decreased cortical volume and thickness around the midshaft. Bone volume (BV), bone area (B.Ar), bone perimeter (B.Pm) and
cortical thickness (Ct.Th) were determined (n = 6 (KO) and 12 (FF)) (*p,0.05; **p,0.01; ***p,0.001). Differences between values from KO and FF mice
(expressed as %) are also included (C) Representative images of distal femur diaphysis and (D) femur cortical bone from control and knockout mice
are also shown.
doi:10.1371/journal.pone.0102032.g004
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Figure 5. p38a deletion in osteoblasts affects the expression of osteogenic markers. (A) Graphs show fibroblast-colony forming units
(CFU-F) (upper panel) and osteoblast-colony forming units (Ob-CFU) of mesenchymal stem cells from bone marrow of FF and KO long bones (n = 9
per genotype). Representative images are also shown. (B&C) qRT-PCR of mRNA extracted from calvariae (B) and long bones (bone-marrow flushed out
tibiae and femurs) (C) of 12-week-old mice (n = 4 (KO) and 8 (FF) independent animals). (D) Protein levels of OSX and p38a were decreased in calvaria
from knockout mice. Left panel: western blot of calvarial bones showing Osterix (OSX), RUNX2, p38a and alpha-TUBULIN as control. Right panel:
graph depicting densitometric analysis of western blots (n = 3(KO) and 6(FF)) (*p,0.05; **p,0.01; ***p,0.001).
doi:10.1371/journal.pone.0102032.g005
p38a Is Required for Bone Homeostasis in Adult Mice
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cortical strength. Similar mechanisms of compensation in aged
mice have been suggested in different models of bone loss in
rodents [36,37,40]. When p38a was deleted after peak bone
values, the cumulative reduction in cortical bone volume and
thickness became apparent only after 60 weeks of age. Thus, in
addition to its role in early skeletogenesis and mineralization, p38a
is also essential for differentiation of osteoblasts and/or for
osteoblasts to maintain their function in mineralized adult bone.
As a result of this, our data also show that efficient bone
remodelling throughout life requires p38 function and that
inhibition of this signalling pathway would result in significant
osteoblast malfunction during chronic treatments. Several chem-
ical p38 MAPK inhibitors have been developed and envisaged as
potential autoimmune or anti-inflammatory drugs as well as
inhibitors of neuropathic pain [41,42]. Our data support the view
that osteoporotic side-effects should be taken into account, even
for highly selective p38 kinase inhibitors. Similarly, the effects of
p38 signalling on the bone resorption activity of osteoclasts should
also be analyzed. Inhibition of p38 signalling in osteoclasts has
been shown to reduce their resorptive activity and improve
trabecular bone loss induced by estrogen deficiency [10].
Bone remodelling depends on a highly coupled balance between
osteoblast and osteoclast functions. Even though osteoblast
function was defective, no significant differences in Rankl/Opg
ratio or in TRAP staining of tibiae were found and only a slight,
but not significant, decrease in serum NTX was obtained in p38a-
deficient mice. These results indicate that impaired osteoblast
function due to the lack of p38a did not severely modify osteoclast
function. Moreover, the effects of p38a deletion were also marked
during differentiation of osteoblast cultures in vitro or osteoblasto-
genesis from mesenchymal stem cells, confirming that changes in
osteoblast function are cell-autonomous and do not rely on
inaccurate osteoblast-osteoclast communication.
p38a activation is normally associated with anti-proliferative
functions, since negative regulation of proliferation has emerged as
a highly conserved function of p38a in various types of primary
cells [43]. We could not find changes in osteoblast proliferation
and/or apoptosis that could explain their lower function in vivo.
Similar absence of effects on proliferation and/or apoptosis has
Figure 6. p38a blockage does not affect bone resorption parameters. (A) Rankl, Opg and Trap mRNA levels in long bones from knockout and
control mice (n = 5 (KO) and 8 (FF) independent animals). (B) The Rankl/Opg expression ratio was not modified. (C) N-terminal telopeptides of collagen
from serum of 12-weeks-old mice do not display significant differences between control and knockout mice (n = 4 (KO) and 10 (FF) independent
animals). (*p,0.05; **p,0.01). (D) TRAP staining of proximal tibiae from FF and KO mice (n = 3 per genotype) showed no differences in osteoclast
parameters (N.Oc./B.S., numbers of osteoclast/Bone perimeter; Oc. S./B.S, osteoclast surface/Bone perimeter). Data is presented as means 6 SEM.
Image shows representative images counterstained with fast green (206 and 406magnification).
doi:10.1371/journal.pone.0102032.g006
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been demonstrated in vitro in mesenchymal osteoblast precursors
[9,44]. Thus, our data imply that p38a-deficient osteoblasts have a
cell-autonomous defect in differentiation potential that impairs
their osteogenic and mineralizing function. Moreover, additional
effects of p38a deficiency in bone turnover could involve the
ability of p38 signalling to modulate the motility of osteoprecursors
and osteoblasts. Although not addressed in this report, migration
of mesenchymal stem cells in vitro has been shown to depend on
p38 kinase activity and mouse models of impaired motility of
osteoblasts also result in reduced bone mass [45,46,47]
It was previously suggested that, since only mice with deletion at
MKK6, and not MKK3, had calvarial hypomineralization,
signalling from distinct p38 isoforms could differently affect
intramembranous and endochondral ossification [5]. Further-
more, although whole-body deletion of p38b in mice was reported
to have no major phenotype, it was later shown that they had
osteopenia of long bones [7,48]. Our results indicate that p38a is
an indispensable isoform involved in both intramembranous and
endochondral bone development. Deletion of p38a during
embryogenesis affected intramembranous calvarial bone develop-
ment as early as on postnatal day 7. Similarly long bones arising
from endochondral ossification also showed an important reduc-
tion in both trabecular and cortical bone at very early
developmental stages. So far no major differences in substrates
and transcriptional targets activated by p38a or p38b have been
shown, suggesting their functional redundancy [49]. It could thus
be hypothesized that the relative role of these two subunits would
largely depend on their differential tissue expression and/or
activity in osteoblast cells.
Mechanistically, in our mice model, lack of p38a leads to similar
changes in the expression of osteoblast-specific transcription
factors in calvaria, long bone and in vitro osteoblast cultures.
Whereas expression levels of Dlx3, Dlx5 or Runx2 did not show
significant changes and Msx2 decreased only in calvaria, Osx levels
decreased in all three conditions. These results corroborate in vitro
data for which chemical inhibition of p38 signalling did not
change Dlx3, Dlx5 or Runx2 expression, but blocked the
transcriptional induction of Osx expression by BMP2 [13]. OSX
have been shown to regulate transcriptionally the expression of
Col1a1, Ibsp, Bglap and Dkk1 [14,15,50,51,52]. Lower levels of
OSX could account for impaired osteoblast maturation and
function, through decreased transcription of these osteoblast and/
or osteocyte genes. Furthermore, evidence demonstrates that
several osteoblast-determining transcription factors are substrates
of p38 and ERK MAPKs. It had previously been shown that
DLX5, RUNX2 and OSX are substrates of p38 and multiple
phosphorylated serines were identified [7,13,14,16]. Phosphoryla-
tion of these factors promotes increased transcriptional activities
for all of them through better recruitment of the transcriptional
cofactor p300/CBP or the SWI/SNF subunit Brg1 [7,13,15].
Therefore, phosphorylation of DLX5, RUNX2 and OSX by p38
signalling constitutes an integration point, at which extracellular
stimuli converge in the regulation of this MAPK. As a result, p38-
dependent phosphorylation promotes their transcriptional activity
and induces osteoblast maturation and function in bone remod-
Figure 7. In vitro analysis of primary cultures reproduces the gene expression disturbances seen in vivo. (A) Images show bone chips
and isolated osteoblasts from KO animals after collagenase treatment. From left to right: 1, 2, 3 and 5 days post-digestion. Endogenous GFP
expression from the Osx1-GFP::Cre transgene is lost as culture advances. (B) BrdU incorporation on primary osteoblasts cultures. (C) qRT-PCR reveals
the comparative mRNA expression levels of Col1a1, Bglap (OC), Osx and Runx2 in primary cultures of osteoblasts from control and knockout pups
(n = 6 independent animals per genotype). (*p,0.05; **p,0.01).
doi:10.1371/journal.pone.0102032.g007
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Figure 8. p38a is necessary for adult bone homeostasis. (A) Scheme of doxycyline (doxi) administration and sacrifice of the different mice
groups analyzed. (B) The distal femoral epiphysis of control and knockout mice after different time of doxycycline (doxi) treatments (3 or 8 weeks)
were analyzed by mCT at 30 or 60 weeks of age. Trabecular bone volume (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th) and
trabecular separation (Tb.Sp.) were determined (n = 5 (KO) and 8 (FF)). (C) Cortical bone volume (BV), bone area (B.Ar), bone perimeter (B.Pm) and
thickness (Ct.Th) analysis was performed in femur midshafts from these animals (n = 5–8). Data are presented as means6 SEM. (*p,0.05). Differences
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eling and homeostasis. Our results agree with previously demon-
strated requirements of OSX function for skeletal maintenance
and osteoblast and osteocyte function during adulthood [53].
In summary, our data demonstrate that p38a is necessary both
in early skeletogenesis, as well as in the maintenance of osteoblast
differentiation and function during bone remodeling in adult life.
Loss of p38a in osteoblasts impairs the expression and phosphor-
ylation of osteoblast-specific transcription factors, blocking further
osteoblast maturation and function. Our data also emphasize that
clinical development of p38 inhibitors should take into account
their potential effects on bone.
Materials and Methods
Generation of conditional Mapk14 knockout mice
To delete p38a (Mapk14) specifically in osteochondroprogeni-
tors, mice carrying loxP sequences flanking p38a alleles (a
generous gift from Drs. Nebreda and Dr Pasparakis [54]) were
crossed with Osx1-GFP::Cre (Osx:Cre) [19]. As the resulting Osx1-
GFP::Cre;Mapk14f/f (KO) were fertile and born in the anticipated
Mendelian ratio, they were crossed with Mapk14f/f (FF) to generate
sibling control and KO mice. The Osx-Cre mouse line contains a
tTA and a tetracycline-responsive element that allows the
expression of Cre recombinase only in the absence of doxycycline.
By maintaining the animals under a doxycycline regime (0.2 mg/
ml in drinking water) we were able to control the timing of p38a
excision. Three different regimes were examined: (1) doxycycline
during pregnancy; (2) either until 3 weeks or until 8 weeks of
postnatal life; (3) no doxycycline treatment to pregnant mothers or
newborns (Fig. 8A). The mice were housed under controlled
conditions (12 h-light/12 h-dark cycle, 21uC, 55% humidity) and
fed ad libitum with water and a 14% protein diet (Teklad 2014,
Harlan). Unless otherwise stated, all experiments were performed
in male mice. All animal protocols were approved by the Ethics
Committee for Animal Experimentation of the University of
Barcelona (Barcelona, Spain).
Genotyping (PCR)
Total DNA was extracted from a 3 mm piece of mouse tail. The
Osx1-GFP::Cre transgene was identified by PCR using the
following primers: OsxCre1: 59-CTC TTC ATG AGG AGG
ACC CT and OsxTGCK: 59-GCC AGG CAG GTG CCT GGA
CAT giving a resulting PCR band of 510 bp. The Mapk14 lox-P
cassette was identified by the primers FloxX: 59-CTACAGAATG-
CACCTCGGATG and FloxY: 59- AGAAGGCTGGATTTG-
CACAAG (resulting bands of 188 for the floxed allele and 121 for
the wild-type). Effective recombination was assessed by PCR of
bone samples using the Flox X primer and the FloxZ: 59-
CCAGCACTTGGAAGGCTATTC, resulting in a band of
411 bp.
Immunoblot analysis
Protein lysates were prepared from bone samples homogenized
with a Polytron device in 50 mM Tris, pH 6.8, 10% glycerol and
1% SDS, separated by SDS-polyacrylamide gel electrophoresis,
transferred to nitrocellulose and analyzed by immunoblotting.
Membranes were incubated with specific antibodies for p38a
(1:1000 Cell Signaling), p-p38 (Cell 1:1000 Cell Signaling), p-
CREB (1:1000 Cell Signalling), OSTERIX (1:1000 Abcam)
RUNX2 (1:1000 MBL) and a-TUBULIN (1:5000 Sigma).
Horseradish peroxidase-conjugated anti-rabbit and anti-mouse
secondary antibodies were used (GE).
Primary osteoblast cultures and CFUs
Primary osteoblasts were seeded in culture after collagenase
digestion of calvariae from P1–P4 mice pups. Bones were dissected
from euthanized pups and their sutures and soft tissue were
discarded. 8–12 calvariae were pooled per genotype and serially
digested in a trypsin (0.025%)/collagenase II solution (1 mg/ml).
The product of the first 5 minutes of digestion was discarded,
while the product of a double 40-minute digestion was centrifuged
(1200 rpm, 5 min.) and seeded on 60 mm culture plates. Primary
osteoblasts were cultured in a-MEM with10% Fetal Bovine Serum
(FBS) and penicillin-streptomycin (P-S). The cultures were
expanded and used between passages 2–3. For colony-forming
units (CFUs) assay bone marrow cells were flushed from tibiae and
femurs from 8-week old FF and KO mice. Cells were seeded in
DMEM with 10%FBS and the medium was replaced every 3 days.
When the cultures reached 70% of confluence, attached cells were
tripsinized for 3 minutes at room temperature and expanded.
Then 5000 cells were seeded per well (6-well plate). For CFU-
Fibroblasts, cultures were fixed and stained with crystal violet
solution (0.2% crystal violet, 2% ethanol) for 30 minutes at 37uC.
Then wells were washed with tap water and air-dried. Colonies
(greater than 50 cells) were counted. For CFU-Osteoblasts, cells
were grown in osteoblast differentiation medium (a-MEM,
10%FBS, 10 mM beta-glycerophophate, 50 mg/ml vitamin C,
1 nM dexamethasone and P-S) for 18 days. Colonies were stained
for alkaline phosphatase activity using alkaline phosphatase kit
from Sigma (86-R). Positive ALP colonies (bigger than 50 cells)
were counted.
Radiographic and mCT analysis
For conventional radiography 8 week-old mice were anesthe-
tized with isofluorane and lateral radiographies were taken with a
portable device. For mCT mice were euthanized at different ages
and their hind limbs were dissected and cleaned of soft tissue.
Femur and tibia were fixed in 4% PFA for 24 hours and stored in
PBS with sodium azide at 4uC until the analysis. The mCT image
was acquired through an aluminum filter of 1 mm, with the
samples in air in a SkyScan 1076 High resolution in-vivo micro-
CT scanner (SkyScan, Kontich, Belgium). Selection of the scan
energy and voxel size was based on optimizing the requirements of
scanning time and tissue detail. The following conditions were
used: 9 mm isotropic voxel size was used, at 50 kV, 200 mA with an
exposure time of 1600 ms and 180u rotation. Scans were
reconstructed using the Recon software provided by SkyScan. For
trabecular measurements, a 1 mm-diameter circular VOI was
employed, starting at 100 slices from the distal growth plate of the
femur and extending to the diaphysis for 150 slices. Cortical
measurements were computed manually delineating the femur
medial cortex for 100 slices around the femur midshaft. A
Gaussian noise filter was applied for the reconstruction. The
CTscan SkyScan software was used for image analysis A global
binary threshold was manually established at 25 for trabecular
analysis and 155 for cortical analysis.
between values from KO and FF mice (expressed as %) are also included. (D) qRT-PCR showing gene expression of calvariae from 30-week old FF and
KO mice treated with doxycycline until 3 weeks of age (Doxi 3–30). Graph shows levels of p38a (Mapk14), Runx2, bone sialoproteı¨na (Ibsp), osterix (Osx)
and osteocalcin (Oc) (FF n = 4, KO n = 5) (*p,0.05; **p,0.01).
doi:10.1371/journal.pone.0102032.g008
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Histological preparations
For histological preparations, samples were fixed in 4%
paraformaldehyde for 24 h at 4uC, decalcified in EDTA and
HCl for 2–4 days at 4uC and processed for paraffin embedding.
Samples were cut in 4 mm sections and stained with toluidine blue,
Masson’s trichrome or hematoxylin/eosin. To reveal changes in
cartilage and bone of the entire skeleton, P7 newborn mice were
sequentially stained with alcian blue (0.015% alcian blue 8GX)
and alizarin red (0.005% alizarin sodium sulfate) after fixation with
95% ethanol. Samples were cleared with 1% KOH and
maintained in glycerol:ethanol (1:1). For TRAP staining, long
bone samples were decalcified in EDTA for 10 days and processed
for paraffin embedding. Deparaffinied slides were prewarmed with
basic incubation solution (sodium acetate, sodium tartrate and
glacial acetic acid) for 30 minutes at 37uC. Then, naphtol-ether
substrate (naphtol AS-BI phosphate, 2-ethoxiethanol) was added.
After 1 hour incubation at 37uC, slides were placed in a new
bucket containing basic incubation buffer plus sodium nitrite and
pararonsaniline dye (pararosaniline dye in 2 N HCl) in order to
develop specific osteoclast staining (5 minutes, 37uC). Preparations
were counterstained with 0.02% fast green for 45 seconds. 3
different sections from 3 independent animals were analyzed per
genotype.
qRT-PCR
Bone samples were dissected from euthanatized animals and
immediately frozen in liquid nitrogen. Prior to congelation bone
marrow was removed from long bones. For that purpose, epiphysis
were cut and discarded and, by means of a 26G-needle, PBS was
flushed through the diaphysis until bone marrow was removed.
Bone samples were individually homogenized using a Polytron
device and RNA was extracted from bone or cell samples by
TriSure (Bioline). RNA from tissue samples was extracted and
processed individually. A minimum of 4 samples (from different
animals) per group was considered for each experiment (n stated in
Figure Legends). At least 2 mg of purified RNA were retro-
transcribed using the High Capacity Retrotranscription Kit
(Applied Biosystems). Quantitative PCRs used an ABI Prism
7900 HT Fast Real-Time PCR System and a Taqman 59-nuclease
probe method or customized TLDA arrays (Applied Biosystems).
50 ng of cDNA were used per reaction (two replicates per sample)
on a 384-well plate. All transcripts were normalized to Gapdh
expression.
BrdU incorporation and serum analysis
For the BrdU incorporation assay 2000 cells per well were
seeded in a 96-well culture plate. 24 hours later, BrdU labeling
solution was added for 4 hours. BrdU incorporation into DNA
was quantified with the Cell Proliferation ELISA kit (Roche).
Blood was collected from posterior vena cava. It was left to clot for
1–2 h at room temperature and centrifuge at 1000G to obtain
blood serum, which was immediately frozen at 280uC for
posterior analysis. Cross-linked N-telopeptides of type I collagen
(NTX) in mouse serum were measured by ELISA kits (Cusabio
Biotec, CO). Alkaline Phosphatase (ALP) levels were determined
following the recommendations of the International Federation of
Clinical Chemistry. For calcium and phosphate concentration, the
arsenazo III and molibdate methods were applied respectively.
ALP, calcium and phosphate levels were analyzed at the Clinical
Biochemistry Service of the Faculty of Veterinary Medicine
(Universitat Auto`noma de Barcelona) using an Olympus AU400
analyzer.
Statistical analysis
The Student’s t test was employed for statistical analysis.
Quantitative data were presented as means 6 SEM. Differences
were considered significant at p values of less than 0.05: *p,.05,
**p,.01, and ***p,.001.
Supporting Information
Figure S1 Weight progression curves show decreased weight
gain in knockout mice compared to control or Osx1-GFP::Cre
mice along 18 weeks (n = 9 (KO) and 18 (FF)).
(TIF)
Figure S2 Calcium and phosphate levels remain unchanged. (A)
Table shows blood serum levels of calcium (Ca), phosphate (Pi)
and alkaline phosphatase from 12 week-old FF and KO mice.
Data show no differences between FF and KO, either in fed (p.
0,05) or fasted state (p.0,05) (n = 13–16). (B) Urine levels of
calcium and phosphate are shown relative to creatinine (Cr)
excretion levels (n = 9–16). (*p,0,05; **p,0,01).
(TIF)
Figure S3 Representative images of distal femur diaphysis and
femur cortical bone from control and knockout mice subjected to
the distinct doxycycline administration and sacrifice regimes.
(TIF)
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